Select Pharmaceuticals Portfolio is a registered fund series of Fidelity Select Portfolios (series S000007481). Net assets $1.5B as of 2026-05-31.
Showing 15 of 57 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| ELI LILLY and CO | — | $431.8M | 2877.51% |
| GSK PLC | — | $122.6M | 816.72% |
| VIATRIS INC | — | $81.8M | 545.24% |
| UCB SA | — | $76.4M | 508.83% |
| MERCK and CO INC | — | $71.2M | 474.13% |
| ROCHE HOLDING AG | — | $68.2M | 454.37% |
| LEGEND BIOTECH CORP | — | $68.0M | 453.26% |
| ASTRAZENECA PLC | — | $63.4M | 422.32% |
| ELANCO ANIMAL HEALTH INC | — | $62.3M | 414.95% |
| JAZZ PHARMACEUTICALS PLC | — | $61.4M | 409.09% |
| GILEAD SCIENCES INC | — | $59.5M | 396.65% |
| JOHNSON and JOHNSON | — | $56.6M | 377.17% |
| ROYALTY PHARMA PLC | — | $40.1M | 267.11% |
| Fidelity Revere Street Trust | — | $36.7M | 244.25% |
| MODERNA INC | — | $23.6M | 156.97% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $1.5B |
| 2026-02-28 | $1.5B |
| 2025-11-30 | $1.3B |
| 2025-08-31 | $1.1B |
| 2025-05-31 | $1.1B |
| 2025-02-28 | $1.3B |
| 2024-11-30 | $1.4B |
| 2024-08-31 | $1.9B |